Article
04 Nov 2025
Double Patenting Without Evergreening: Missing The Forest For The Trees?
Andrew Shaughnessy
Popular Topics
Intellectual Property
AUTHORS CONTENT
Article
12 Dec 2024
Fostering Innovation And Protecting Investments: Patent Law's Double-Edged Sword And Environmental Technologies
Article
10 Dec 2024
The Latest On Canada's Patented Medicine Prices Review Board: Not The "All Medicine Prices Review Board"
Article
18 Sep 2024
Is It Real Or Is It Memorex? Does AI Threaten IP?
Article
16 Aug 2024
Ask An IP Litigator: Do I Have A Great Patent? (Video)
Article
30 Apr 2024
Federal Court Of Appeal Underscores The Importance Of Patent Terms In Invalidating Claims To "Physiologically Acceptable" Salts
Article
28 Feb 2024
Federal Court Of Appeal Limits Scope Of Prohibition Against Patenting Methods Of Medical Treatment
Article
02 Feb 2024
Patent On Differin XP Gives PMPRB Pricing Jurisdiction Over Differin: Federal Court
Article
22 Dec 2023
Federal Court Of Appeal "Skinny Label" Case Highlights The Potential Power Of The Patentee
Article
05 Oct 2023
Interim Pricing Guidance Adopted As Canada's PMPRB Continues To Move Towards New Guidelines
Article
14 Dec 2022
FCA: PMPRB11 Stands For Patented Medicines
Article
26 Oct 2022
Four Life Sciences Regulatory And Litigation Trends And Their Practical Impact
Article
14 Oct 2022
Canada's PMPRB Guidelines Proposed For Stakeholder Consultation
Article
07 Jul 2022
Court Endorses Three-Step Approach For Assessing Computer-Enabled Subject Matter
Article
19 Apr 2022
Is The Pendulum Swinging Back? Salt Selection And Crystal Form Patents Not Necessarily Obvious
Article
30 Mar 2022
Back To The Pricing Board: Supreme Court Of Canada Will Not Hear Appeal In Soliris Pricing Decision
Article
28 Feb 2022
A Sense Of Déjà Vu: The Québec Court Of Appeal Rules On Constitutionality Of PMPRB
Article
04 Feb 2022
Inducing A Summary Trial: Federal Court Determines Indirect Infringement Using The Summary Trial Procedure
Article
21 Dec 2021
Brave New (Meta) World—Nike Files Virtual Trademarks: Implications For Canadian Trademark Law
Article
16 Dec 2021
Pharma: A Year In Review Through The Lens Of Our Trading Partner To The South
AWARDS
